CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Vanda Pharmaceuticals Inc. v. Apotex Inc.

1:24-cv-01344

Overview

Case Number 1:24-cv-01344
Filing Date 2024-12-09
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Apotex Corp. Operating Company

Represented By

1 Attorneys Listed

Kaan Ekiner

Cozen O'Connor

Tel: +1 (302) 295-2046

Cozen O'Connor, 1201 North Market Street

Apotex Inc. Operating Company

Represented By

1 Attorneys Listed

Kaan Ekiner

Cozen O'Connor

Tel: +1 (302) 295-2046

Cozen O'Connor, 1201 North Market Street

Plaintiff

Vanda Pharmaceuticals Inc. Operating Company

Represented By

7 Attorneys Listed

Sarah P. Hogarth

Email: shogarth@mwe.com

Samoneh Kadivar Schickel

Email: sschickel@mwe.com

Paul W. Hughes

Email: phughes@mwe.com

Mary H. Schnoor

Email: mschnoor@mwe.com

Jason A. Leonard

Email: jleonard@mwe.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 17 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (17): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11918556
Treatment of circadian rhythm disorders
Filed: 2022-02-15
Issued: 2024-03-05
Active (6.4 yrs remaining)
Expires: 2033-04-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 4

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME the deadline for the parties to submit (i) a proposed Scheduling Order; and (ii) a joint letter setting forth (a) a description of th...
Entry #18 • 2025-04-24 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME the deadline for the parties to submit (i) a proposed Scheduling Order; and (ii) a joint letter setting forth (a) a description of th...
Entry #17 • 2025-04-16 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 8 Stipulation and Order to Extend Time for Defendants to move, plead, or otherwise respond to Plaintiff's First Amended Complaint to March 17, 20...
Entry #β€” • 2025-02-13
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants to move, plead, or otherwise respond to Plaintiff's First Amended Complaint to March 17, 2025 - filed by Apotex Corp.,...
Entry #8 • 2025-02-12 Document →

Docket Entries

(39 total)
Pleading / Complaint

COMPLAINT for Patent Infringement with Jury Demand against Apotex Corp., Apotex Inc. (Filing fee $ 405, receipt number ADEDC-4565504) - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibits A-H, # 2 Civil Cover Sheet)(oam) (Entered: 12/10/2024)

Entry #1 • 2024-12-09
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 12/10/2024)

Entry #2 • 2024-12-09
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,918,556. (oam) (Entered: 12/10/2024)

Entry #3 • 2024-12-09
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Black Rock Fund Advisors for Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc. (oam) (Entered: 12/10/2024)

Entry #4 • 2024-12-09
1

Summons Issued as to Apotex Corp., Apotex Inc.. (Attachments: # 1 Summons Issued)(oam) (Entered: 12/10/2024)

Entry #5 • 2024-12-09
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc